MedPath

Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.

Conditions
Hypertensive Disorder of Pregnancy
Sleep-disordered Breathing
Registration Number
NCT04126629
Lead Sponsor
The Cooper Health System
Brief Summary

This study aims to assess the prevalence of sleep disorder breathing in pregnant women with a singleton gestation who develop hypertensive disorder of pregnancy (HDP) compared to women without HDP, when matched for gestational age and body mass index.

Detailed Description

Sleeping disorder breathing is not only underdiagnosed in the general population, but more specifically in pregnant women. Some recent research has found an association between sleep disorder breathing and preeclampsia. Both conditions have shown to be associated with worse pregnancy outcomes. Therefore, more research is needed to find the strength of these associations. By gathering more information, this provides investigators with an opportunity to see if there is a way to slow the progression of complications in preeclampsia through the management of sleep-disordered breathing. Preeclampsia continues to be one of the top reasons for maternal mortality in the U.S. and this percentage continues to grow each year. Through the study, investigators hope to bring awareness of the comorbidity and how its similar pathogenesis can potential exacerbate complications in pregnant women.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
    1. Subject who is capable of consenting in English
  • 2.Women with a diagnosis of a hypertensive disorder of pregnancy
  • 3.Greater than 20 weeks pregnant
  • 4.Singleton fetus
  • 5.Inpatient
Exclusion Criteria
  • 1.With acute respiratory distress, including asthma
  • 2.With micrognathia and other severe craniofacial abnormalities
  • 3.Active heart failure
  • 4.Sepsis
  • 5.Subjects in labor.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of SDB in women with HDP compared to normotensive women.03/01/2019-03/01/2021
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cooper University Hospital

🇺🇸

Camden, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath